Skip to Content

Xlife Sciences AG Ordinary Shares XLS

Morningstar Rating
CHF 29.00 +0.20 (0.69%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

XLS is trading at a 581% premium.
Price
CHF 28.61
Fair Value
CHF 75.29
Uncertainty
Extreme
1-Star Price
CHF 785.14
5-Star Price
CHF 95.18
Economic Moat
Hzq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XLS is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 28.80
Day Range
CHF 28.6029.00
52-Week Range
CHF 27.5051.40
Bid/Ask
CHF 29.00 / CHF 29.40
Market Cap
CHF 165.40 Mil
Volume/Avg
679 / 4,913

Key Statistics

Price/Earnings (Normalized)
Price/Sales
211.06
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
17

Comparables

Valuation

Metric
XLS
MLTX
KOMN
Price/Earnings (Normalized)
16.39
Price/Book Value
0.605.281.72
Price/Sales
211.060.89
Price/Cash Flow
43.5411.64
Price/Earnings
XLS
MLTX
KOMN

Financial Strength

Metric
XLS
MLTX
KOMN
Quick Ratio
3.1161.561.71
Current Ratio
3.1162.133.11
Interest Coverage
12.7012.75
Quick Ratio
XLS
MLTX
KOMN

Profitability

Metric
XLS
MLTX
KOMN
Return on Assets (Normalized)
−7.80%−9.28%5.48%
Return on Equity (Normalized)
−15.67%−10.06%10.15%
Return on Invested Capital (Normalized)
−9.47%−9.46%7.66%
Return on Assets
XLS
MLTX
KOMN
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
NtjxlfcrXbtj$584.2 Bil
Vertex Pharmaceuticals Inc
VRTX
DcvhbsvxQszqcw$126.7 Bil
Regeneron Pharmaceuticals Inc
REGN
TvrfskqPwxhnw$116.9 Bil
Moderna Inc
MRNA
GklbgwyhCcm$45.3 Bil
Alnylam Pharmaceuticals Inc
ALNY
VkgnmplYxjgrbj$29.9 Bil
argenx SE ADR
ARGX
NyzrdmcjyQqsy$27.8 Bil
BioNTech SE ADR
BNTX
YbjddbjRsnw$20.0 Bil
Biomarin Pharmaceutical Inc
BMRN
MymgqzpRzpfzv$16.1 Bil
United Therapeutics Corp
UTHR
ZywntrfyQmxlj$14.7 Bil
Incyte Corp
INCY
XjftgrmNxdyrpc$13.2 Bil

Sponsor Center